Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trypan blue staining in vitreoretinal surgery.

Francisco Aguilera Teba1, Andreas Mohr, Claus Eckardt

  • 1Instituto Oftalmico de Jaen, Jaen, Spain.

Ophthalmology
|December 3, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Chemotherapy and Radiotherapy on Iris Metastases: A Case Report.

Ocular oncology and pathology·2026
Same author

Ocular Safety Signals of Fibroblast Growth Factor Receptor Inhibitors in Postmarketing Surveillance.

American journal of ophthalmology·2026
Same author

<sup>68</sup>Ga-FAPI-46 PET/CT Versus <sup>18</sup>F-FDG PET/CT for Pancreatic Cancer: A Feasibility Study.

Journal of medical imaging and radiation oncology·2026
Same author

1-2-3-4 Sign FDG PET Sign in Sarcoidosis.

Journal of medical imaging and radiation oncology·2026
Same author

Immune Mediators in Birdshot Chorioretinopathy: A Systematic Review.

Ocular immunology and inflammation·2026
Same author

Factors Associated With the Usability and Adoption of Continuous Monitoring Devices With Deterioration Alerting Systems in Acute Hospital Non-ICU Settings: A Mixed Methods Study.

Journal of nursing management·2026
Same journal

Value of 10-2 Visual Field Testing for Detecting Progression in Patients with Glaucoma.

Ophthalmology·2026
Same journal

Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Non-infectious Uveitis.

Ophthalmology·2026
Same journal

Diverse Conjunctival Adverse Events Associated with Tisotumab Vedotin.

Ophthalmology·2026
Same journal

The Answer Is Blowing in the Wind: Uncovering Hidden Glaucoma Risk Factors.

Ophthalmology·2026
Same journal

Nonsteroidal Anti-inflammatory Drug Use Reduces the Risk of Age-Related Macular Degeneration in Electronic Health Record Analysis: Signal or Solution?

Ophthalmology·2026
Same journal

Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

Ophthalmology·2026
See all related articles

Trypan blue effectively stains internal limiting membrane (ILM) and epiretinal membranes (ERM) during vitreoretinal surgery. This dye aids in membrane identification and removal without adverse effects, proving a useful surgical tool.

Area of Science:

  • Ophthalmology
  • Surgical Techniques
  • Biomaterials

Background:

  • Vitreoretinal surgery often requires clear visualization of delicate membranes like the internal limiting membrane (ILM) and epiretinal membranes (ERM).
  • Accurate identification and delineation of these membranes are crucial for successful surgical outcomes in conditions such as macular pucker and macular hole.

Purpose of the Study:

  • To assess the efficacy of trypan blue as a staining agent for the ILM and ERM during vitreoretinal surgical procedures.
  • To determine if trypan blue enhances the intraoperative visualization and facilitates the removal of these epiretinal tissues.

Main Methods:

  • A prospective case series involving 50 eyes of patients undergoing vitreoretinal surgery for various conditions.
  • 0.2% trypan blue solution was applied to stain the ILM or ERM.

Related Experiment Videos

  • Intraoperative membrane visibility was subjectively graded as poor, moderate, good, or excellent.

    • Main Results:

    • Trypan blue provided a distinct bluish stain on both the ILM and ERM in all cases.
    • The staining significantly improved the identification, delineation, and subsequent removal of the target membranes.
    • No instances of residual staining or dye-related adverse effects were reported.

    Conclusions:

    • Trypan blue is an effective staining agent for both ILM and ERM in vitreoretinal surgery.
    • Its ability to enhance membrane visualization suggests it is a valuable adjunct for improving surgical precision and outcomes.